Acute kidney injury - Experimental models

Nagasaki, Yukio; Yoshitomi, Toru; Hirayama, Aki; Schock-Kusch, Daniel; Xie, Qing; Shulhevich, Yury; Hesser, Juergen; Stsepankou, Stsepankou; Koenig, Stefan; Heinrich, Ralf; Pill, Johannes; Gretz, Norbert; Efrati, Shai; Berman, Sylvia; Abu-Hamad, Ramzia; Siman-Tov, Yarive; Weissgarten, Joshua; Kimura, Tomonori; Takabatake, Yoshitsugu; Takahashi, Atsushi; Kaimori, Jun-Ya; Matsui, Isao; Namba, Tomoko; Kitamura, Harumi; Niimura, Fumio; Matsusaka, Taiji; Rakugi, Hiromi; Isaka, Yoshitaka; Ito, Kenji; Watanabe, Maho; Nakashima, Hitoshi; Abe, Yasuhiro; Ifuku, Masakazu; Nishimura, Shinsuke; Saito, Takao; Mulay, Shrikant R.; Thomasová, Dana; Ryu, Mi Heon; Anders, Hans‐Joachim; Nakayama, Yosuke; Ueda, Seinosuke; Yamagishi, Sho‐ichi; Ando, Ryoichi; Kaida, Yusuke; Iwatani, Ryuji; Fujimi, Ayako; Fukami, Kei; Okuda, Seiya; Shin, Young Tai; Jeong, Jin Young; Jang, Won Ik; Chung, Sarah; Choi, Dae Eun; Na, Ki Young; Lee, Kang Wook; Mugitani, Nozomi; Shimizu, Yoshio; Satake, Kenji; Suzuki, Yusuke; Horikoshi, Satoshi; Tomino, Yasuhiko; Schneider, Reinhard; Meusel, Marcus; Betz, Boris; Wanner, Christoph; Koepsell, Hermann; Sauvant, Christoph; Dursun, Belda; Abban, Gülçin; Küçükatay, Vural; Tufan, Lale; Dodurga, Yavuz; Güçlü, Aydın; Gok, Duygu; Vicente-Vicente, Laura; Sánchez-González, Penélope; Prieto, Marta; López‐Hernández, Francisco J.; Morales, Ana Isabel; Torres, Adriana M.; Dnyanmote, Ankur V.; Wu, Wei; Nigám, Sanjay K.; Wystrychowski, Antoni; Wystrychowski, Wojciech; Kołodziejczyk, Agnieszka; Obuchowicz, Ewa; Wiȩcek, Andrzej; Reis, Luciana Aparecida; Borges, Fernanda Teixeira; Simões, Manuel de Jesus; Schor, Nestor; Laurent, Michel; Rafat, Cédric; Vandermeersch, Sophie; Nochy, Dominique; Garçon, Loïc; Callard, P; Jouanneau, Chantal; Verpont, Marie-Christine; Hertig, Alexandre; Rondeau, Éric; Grosjean, Fabrizio; Torreggiani, Massimo; Esposito, Vittoria; Mangione, Filippo; Serpieri, Nicoletta; Villa, Luigi; Sileno, Giuseppe; Marchi, Gianluca; Fasoli, Gianluca; Esposito, Ciro; Canton, Antonio Dal; Sancho-Martínez, Sandra M.; López‐Novoa, José M.; Striker, Gary E.; Vlassara, Helen; Zhao, Feng; Park, Dong Jun; Kim, Jin Hyun; Jung, Myeong Hee; Seo, Jong Woo; Kim, Hyun-Jung; Chang, Se-Ho; Han, Byoung-Geun; Yang, Jae-Won; Yu, Jong-Myeong; Choi, Seung-Ok; Christo, Joelma Santina; Rusai, Krisztina; Prókai, Ágnes; Szebeni, Beáta; Mészáros, Krisztina; Fekete, Andrea; Treszl, András; Vannay, Ádám; Müller, Veronika; Reusz, György; Heemann, Uwe; Tulassay, Tivadar; Lutz, Jens; Szabó, Attila; Ranghino, Andrea; Bruno, Stefania; Grange, Cristina; Dolla, Caterina; Cantaluppi, Vincenzo; Biancone, Luigi; Tetta, Ciro; Segoloni, Giuseppe; Camussi, Giovanni; Pinto, Vitor; Teixeira, Vicente P.C.; Almeida, Waldemar S.; Fujikura, Tomoyuki; Sun, Yuan; Iwakura, Takamasa; Yasuda, Hideo; Fujigaki, Yoshihide; Simone, Simona; Rascio, Federica; Loverre, Antonia; Cosola, Carmela; Cariello, Marica; Castellano, Giancarlo; Ditonno, P.; Schena, Francesco Paolo; Gesualdo, Loreto; Grandaliano, Giuseppe; Giovanni, Pertosa; Choi, Jinhyeok; Kim, Jin; Jin, Dong-Chan; Cha, Jung-Ho; Kaynar, Kubra; Aliyazıcıoğlu, Rezzan; Ersöz, Şafak; Ulusoy, Şükrü; Al, Sait; Özkan, Gülsüm; Cansız, Muammer; Fuchs, T; Emde, Barbara; Czasch, Stephanie; Landenberg, Friedrich von; Hewitt, Philip; Abu-Salah, Niroz; Bishara, Bishara; Awad, Hoda; Ghrayeb, Nabil; Assady, Suhair; Armaly, Zaher; Better, Ori S.; Abassi, Zaid

doi:10.1093/ndtplus/4.s2.46

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…EPO (10,000 U/kg/d) has a protective effect against cardiac remodeling after MI in in vivo mouse models [15]. EPO (1 to 50 U/ml) protects HK-2 cells from H2O2 EPO (300 IU/kg i. v) is able to reduce oxidative stress and caspase-3 activities in H induced cell death in a dose-dependent manner [16]. A study in rat cardiomyocytes showed protection against Angiotensin II-induced cardiomyocyte hypertrophy when EPO administered at a dose of 20 U/ml [17].…”

Section: Introductionmentioning

confidence: 99%

Recombinant Erythropoietin Mitigates Reperfusion Injury in Neonatal Rat Cardiomyocytes by Novel Multiple Signalling Pathways

Allaudeen

Koka

Pant

et al. 2016

Int J Pharm Pharm Sci

View full text Add to dashboard Cite

Objective: Recombinant Human Erythropoietin (rhEPO) is strongly inferred to protect the cardiomyocytes from the reperfusion injury and our aim is to elucidate the cardioprotective effect and the exact mechanism behind the cardioprotection.Methods: Neonatal rat cardiomyocytes (NCM) exposed to Hypoxia/Reperfusion (H/R) with or without pretreatment using various concentrations of rhEPO. To determine the cell viability-MTT assay, Acridine orange and Ethidium Bromide (Ao/EtBr) staining was performed. To determine the reactive oxygen species (ROS) and mitochondrial membrane potential (Δψm), Dichlorofluorescein diacetate (DCF-DA) and Rhodamine-123 was used. To determine the signaling pathways Western blot analysis of pAkt, pp38 MAPK, cytochrome-c were performed.Results: rhEPO was found to reduce the cell death by stabilizing ROS significantly, Δψm, cytochrome c release, and caspase-3. rhEPO, increases the phosphorylation of p38 MAPK, Akt and BAD compared to H/R. Further myocytes blocked with Wortmannin (WT), and SB203580 showed increased caspase-3 activity.Conclusion: Hence we conclude from this study that rhEPO regulated the factors involved in reperfusion injury through modulation of Akt and p38 MAPK pathways.

show abstract

Section: Introductionmentioning

confidence: 99%